More Press Releases

View Older Stories View Newer Stories

May 23, 2024 05:00PM New Research Demonstrates the Importance of Genetic Testing for Many Cancers Not Currently Covered by Clinical Guidelines
May 23, 2024 05:00PM Comvest Partners Announces $70 Million Senior Credit Facility For Nationwide Energy Partners to Support Growth Strategy
May 23, 2024 05:00PM EMD Serono to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
May 23, 2024 05:00PM NeraCare Announces Publication of Abstract on Clinical Validation of a Prognostic 7-Biomarker Assay for Prediction of Relapse in Patients with Early-Stage Cutaneous Melanoma at the 2024 American Socie
May 23, 2024 05:00PM Werewolf Therapeutics to Present Updated Data from Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors at 2024 ASCO Annual Meeting
May 23, 2024 05:00PM THE WALLA WALLA VALLEY BECOMES FIRST CERTIFIED BLUE ZONES COMMUNITY® IN WASHINGTON
May 23, 2024 05:00PM OncoHost to Present Poster Demonstrating PROphet®'s Application in Multiple Cancer Indications at ASCO 2024
May 23, 2024 05:00PM Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:00PM Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:00PM AffyImmune Announces Confirmed Complete Response in Patient with Anaplastic Thyroid Cancer
May 23, 2024 05:00PM Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting
May 23, 2024 05:00PM Incendia Therapeutics Announces Upcoming Presentation with PathAI at the 2024 American Society of Clinical Oncology Annual Meeting
May 23, 2024 05:00PM Klaviyo to Present at the William Blair Growth Stock Conference
May 23, 2024 05:00PM Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors
May 23, 2024 05:00PM Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
May 23, 2024 05:00PM Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting
May 23, 2024 05:00PM MAQUIA CAPITAL ACQUISITION CORPORATION AND IMMERSED INC. MUTUALLY AGREE TO TERMINATE BUSINESS COMBINATION AGREEMENT
May 23, 2024 05:00PM Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO® Annual Meeting
May 23, 2024 05:00PM Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients Non-Responsive to Immune Checkpoint Inhibitor (
May 23, 2024 05:00PM Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
May 23, 2024 05:00PM Dentalcorp Announces Annual General Meeting Voting Results
May 23, 2024 05:00PM Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting
May 23, 2024 05:00PM IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual Meeting
May 23, 2024 05:00PM Tizona Therapeutics Presents Phase 1b TTX-080 Clinical Data in Advanced Colorectal Cancer and Head and Neck Squamous Cell Carcinoma at ASCO 2024
May 23, 2024 05:00PM Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024
May 23, 2024 05:00PM NVIDIA Announces Upcoming Event for Financial Community
May 23, 2024 05:00PM Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 04:59PM Ligand to Participate in Upcoming Investor Conferences
May 23, 2024 04:55PM Park Aerospace Corp. Announces Date of Fiscal Year Earnings Release and Conference Call
May 23, 2024 04:51PM CORRECTION FROM SOURCE: ArcStone Strengthens its Investment Banking Team with Strategic Hires
May 23, 2024 04:49PM THOR Industries Announces Date For Its Fiscal 2024 Third Quarter Earnings Release
May 23, 2024 04:48PM Diamonds de Canada Unveils the Lands Collection at JCK Show in Las Vegas
May 23, 2024 04:45PM Our People: Lora Collins, Woman of Asphalt
May 23, 2024 04:46PM Acme United Corporation Acquires the Assets of Elite First Aid
May 23, 2024 01:30PM Ecora Resources PLC Announces Transaction in Own Shares
May 23, 2024 04:45PM ValueZone Strengthens Resources for Traders in Current Bull Market
May 23, 2024 03:45PM Smith-Midland Reports Fourth Quarter and Year End 2023 Financial Results
May 23, 2024 04:40PM Genworth Financial Announces Results of Annual Meeting
May 23, 2024 04:37PM Tanger Schedules Second Quarter 2024 Earnings Release and Conference Call
May 23, 2024 03:45PM Smith-Midland Reports Fourth Quarter and Year End 2023 Financial Results
May 23, 2024 04:36PM HUB Security Provides an Update on the 2023 Annual Report
May 23, 2024 02:50PM Arkisys(TM) Ground Demo Shows We Can Now Build Satellites in Space
May 23, 2024 04:30PM StageZero Life Sciences Announces Update on Failure to File Cease Trade Order
May 23, 2024 04:31PM Zimbis and DSN Software Announce Strategic Integration to Revolutionize Dental Inventory Management
May 23, 2024 04:31PM The FLCCC Alliance International Fellowship Program Announces 14 New Senior Fellows Across 11 Countries
May 23, 2024 04:30PM Philips successfully prices offering of Notes for EUR 700 million to be used for repayment of existing debt
May 23, 2024 04:30PM Penumbra, Inc. to Present at the William Blair Growth Stock Conference
May 23, 2024 04:30PM Newtopia Reports Fourth Quarter, Full Year 2023 and First Quarter 2024 Financial Results
May 23, 2024 04:30PM THE RAP SNACKS FOUNDATION EXPANDS "BOSS UP EXPERIENCE: ACTIVATE YOUR VSN" TOUR TO DALLAS, MIAMI AND NEW ORLEANS
May 23, 2024 04:30PM Phreesia’s Amy Patel Named One of PM360’s 2024 ELITE 100
View Newer Stories View Older Stories